Clinical Trial Update: HN-BIO 02: A Phase II Randomized Study of the Effects of Delayed Elective Radiotherapy on Head and Neck MRI and Immune Response Biomarkers [NA]

View source ↗

Summary

This clinical trial update announces a Phase II randomized study assessing the effects of delayed elective radiotherapy on head and neck MRI measures and immune…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of Head and Neck

Snippet

Sponsor: University Health Network, Toronto | Conditions: Squamous Cell Carcinoma of Head and Neck | NA | Status: RECRUITING